MBD5 and MBD6 interact with the human PR-DUB complex through their methyl-CpG-binding domain

Proteomics

Volumn 14, Issue 19, 2014, Pages 2179-2189

  Baymaz, H Irem ^a,e   Fournier, Alexandra ^b   Laget, Sophie ^b   Ji, Zongling ^c   Jansen, Pascal W T C ^a,e   Smits, Arne H ^a,e   Ferry, Laure ^b   Mensinga, Anneloes ^a,e   Poser, Ina ^d   Sharrocks, Andrew ^c   Defossez, Pierre Antoine ^b   Vermeulen, Michiel ^a,e  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Université Sorbonne Paris Cité   (France)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cell biology; Chromatin; Protein protein interactions

Indexed keywords

FOXK1 PROTEIN; FOXK2 PROTEIN; METHYL CPG BINDING PROTEIN; METHYL CPG BINDING PROTEIN 1; METHYL CPG BINDING PROTEIN 2; METHYL CPG BINDING PROTEIN 3; METHYL CPG BINDING PROTEIN 4; METHYL CPG BINDING PROTEIN 5; METHYL CPG BINDING PROTEIN 6; POLYCOMB GROUP PROTEIN; PR DUB PROTEIN; PROTEIN; UNCLASSIFIED DRUG; BAP1 PROTEIN, HUMAN; CHROMATIN; DNA BINDING PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; INTERLEUKIN BINDING FACTOR; MBD5 PROTEIN, HUMAN; MBD6 PROTEIN, HUMAN; PROTEIN BINDING; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN THIOLESTERASE;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA DAMAGE; DNA METHYLATION; DNA REPAIR; HUMAN; HUMAN CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN RNA BINDING; STOICHIOMETRY; TRANSIENT TRANSFECTION; UBIQUITINATION; AMINO ACID SEQUENCE; CHROMATIN; HEK293 CELL LINE; HELA CELL LINE; METABOLISM; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; CHROMATIN; DNA DAMAGE; DNA METHYLATION; DNA-BINDING PROTEINS; FORKHEAD TRANSCRIPTION FACTORS; HEK293 CELLS; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; POLYCOMB-GROUP PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE;

EID: 84903215772     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201400013     Document Type: Article

References (45)

1. Hendrich, B., Tweedie, S., The methyl-CpG binding domain and the evolving role of DNAmethylation in animals. Trends Genet. 2003, 19, 269-277.
2. Bird, A., The dinucleotide CG as a genomic signalling module. J. Mol. Biol. 2011, 409, 47-53.
3. Defossez, P. A., Stancheva, I., Biological functions of methyl-CpG-binding proteins. Prog. Mol. Biol. Transl. Sci. 2011, 101, 377-398.
4. Hu, S., Wan, J., Su, Y., Song, Q. et al., DNA methylation presents distinct binding sites for human transcription factors. Elife 2013, 2, e00726.
5. Spruijt, C. G., Gnerlich, F., Smits, A. H., Pfaffeneder, T. et al., Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 2013, 152, 1146-1159.
6. Lewis, J. D., Meehan, R. R., Henzel, W. J., Maurerfogy, I. et al., Purification, Sequence, and Cellular-Localization of a Novel Chromosomal Protein That Binds to Methylated DNA. Cell 1992, 69, 905-914.
7. Nan, X. S., Meehan, R. R., Bird, A., Dissection of the Methyl-Cpg Binding Domain from the Chromosomal ProteinMecp2. Nucleic. Acids Res. 1993, 21, 4886-4892.
8. Fournier, A., Sasai, N., Nakao, M., Defossez, P. A., The role of methyl-binding proteins in chromatin organization and epigenome maintenance. Brief Funct. Genomics 2012, 11, 251-64.
9. Laget, S., Joulie, M., Le Masson, F., Sasai, N. et al., The human proteins MBD5 and MBD6 associate with heterochromatin but they do not bind methylated DNA. PLoS One 2010, 5, e11982.
10. Motobayashi, M., Nishimura-Tadaki, A., Inaba, Y., Kosho, T. et al., Neurodevelopmental features in 2q23.1microdeletion syndrome: report of a new patient with intractable seizures and review of literature. Am J. Med. Genet. A 2012, 158A, 861-868.
11. Du, Y., Liu, B., Guo, F., Xu, G. et al., The essential role ofMbd5 in the regulation of somatic growth and glucose homeostasis in mice. PLoS One 2012, 7, e47358.
12. Scheuermann, J. C., Alonso, A. G. D., Oktaba, K., Ly-Hartig, N. et al., Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB. Nature 2010, 465, 243-U138.
13. Sowa, M. E., Bennett, E. J., Gygi, S. P., Harper, J.W., Defining the human deubiquitinating enzyme interaction landscape. Cell 2009, 138, 389-403.
14. Dey, A., Seshasayee, D., Noubade, R., French, D. M. et al., Loss of the tumor suppressor BAP1 causes myeloid transformation. Science 2012, 337, 1541-1546.
15. Yu, H., Mashtalir, N., Daou, S., Hammond-Martel, I. et al., The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression. Mol. Cell Biol. 2010, 30, 5071-5085.
16. Spruijt, C. G., Baymaz, H. I., Vermeulen, M., Identifying specific protein-DNA interactions using SILAC-based quantitative proteomics. Methods Mol. Biol. 2013, 977, 137-157.
17. Schram, A. W., Baas, R., Jansen, P. W., Riss, A. et al., A dual role for SAGA-associated factor 29 (SGF29) in ER stress survival by coordination of both histone H3 acetylation and histone H3 lysine-4 trimethylation. PLoS One 2013, 8, e70035.
18. Smits, A. H., Jansen, P. W., Poser, I., Hyman, A. A., Vermeulen, M., Stoichiometry of chromatin-associated protein complexes revealed by label-free quantitative mass spectrometry-based proteomics. Nucleic. Acids Res. 2013, 41, e28.
19. Cox, J., Mann, M., MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 2008, 26, 1367-1372.
20. Poser, I., Sarov, M., Hutchins, J. R., Heriche, J. K. et al., BAC TransgeneOmics: a high-throughput method for exploration of protein function in mammals. Nat. Methods 2008, 5, 409-415.
21. Carbone, M., Yang, H. N., Pass, H. I., Krausz, T. et al., BAP1 and cancer. Nature Reviews Cancer 2013, 13, 153-159.
22. Zou, X., Ma, W., Solov'yov, I. A., Chipot, C., Schulten, K., Recognition of methylated DNA through methyl-CpG binding domain proteins. Nucleic. Acids Res. 2012, 40, 2747-2758.
23. Mayer, C., Schmitz, K. M., Li, J., Grummt, I., Santoro, R., Intergenic transcripts regulate the epigenetic state of rRNA genes. Mol. Cell 2006, 22, 351-361.
24. Iurlaro, M., Ficz, G., Oxley, D., Raiber, E. A. et al., A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation. Genome Biol. 2013, 14, R119.
25. Yang, Q., Kong, Y., Rothermel, B., Garry, D. J. et al., The winged-helix/forkhead protein myocyte nuclear factor beta (MNF-beta) forms a co-repressor complex with mammalian sin3B. Biochem. J. 2000, 345, 335-343.
26. Shi, X., Garry, D. J., Sin3 interacts with Foxk1 and regulates myogenic progenitors. Mol. Cell Biochem. 2012, 366, 251-258.
27. Shi, X., Seldin, D. C., Garry, D. J., Foxk1 recruits the Sds3 complex and represses gene expression in myogenic progenitors. Biochem. J. 2012, 446, 349-357.
28. Marais, A., Ji, Z., Child, E. S., Krause, E. et al., Cell cycledependent regulation of the forkhead transcription factor FOXK2 by CDK. cyclin complexes. J. Biol. Chem. 2010, 285, 35728-35739.
29. Schwanhausser, B., Busse, D., Li, N., Dittmar, G. et al., Global quantification of mammalian gene expression control. Nature 2011, 473, 337-342.
30. Ji, Z., Donaldson, I. J., Liu, J., Hayes, A. et al., The forkhead transcription factor FOXK2 promotes AP-1-mediated transcriptional regulation. Mol. Cell Biol. 2012, 32, 385-398.
31. Harper, J. W., Elledge, S. J., The DNA damage response: ten years after. Mol. Cell 2007, 28, 739-745.
32. Zhou, W., Wang, X., Rosenfeld, M. G., Histone H2A ubiquitination in transcriptional regulation and DNA damage repair. Int. J. Biochem. Cell Biol. 2009, 41, 12-15.
33. Jacq, X., Kemp, M., Martin, N. M., Jackson, S. P., Deubiquitylating Deubiquitylating enzymes and DNA damage response pathways. Cell Biochem. Biophys. 2013, 67, 25-43.
34. Yu, H., Pak, H., Hammond-Martel, I., Ghram, M. et al., Tumor suppressor and deubiquitinase BAP1 promotesDNAdoublestrand break repair. Proc. Natl. Acad Sci. U. S. A. 2014, 111, 285-290.
35. Carbone, M., Ferris, L. K., Baumann, F., Napolitano, A. et al., BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, andMBAITs. J. Transl. Med. 2012, 10.
36. Pena-Llopis, S., Vega-Rubin-de-Celis, S., Liao, A., Leng, N. et al., BAP1 loss defines a new class of renal cell carcinoma. Nat. Genet 2012, 44, 751-759.
37. Abdel-Wahab, O., Dey, A., The ASXL-BAP1 axis: new factors inmyelopoiesis, cancer and epigenetics. Leukemia 2013, 27, 10-15.
38. Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S. et al., Cancer genome landscapes. Science 2013, 339, 1546-1558.
39. Misaghi, S., Ottosen, S., Izrael-Tomasevic, A., Arnott, D. et al., Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1. Mol. Cell Biol. 2009, 29, 2181-2192.
40. Machida, Y. J., Machida, Y., Vashisht, A. A., Wohlschlegel, J. A., Dutta, A., The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. J. Biol. Chem. 2009, 284, 34179-34188.
41. Eletr, Z. M., Wilkinson, K. D., An emerging model for BAP1's role in regulating cell cycle progression. Cell Biochem. Biophys. 2011, 60, 3-11.
42. Aravind, L., Landsman, D., AT-hook motifs identified in a wide variety of DNA-binding proteins. Nucleic. Acids Res. 1998, 26, 4413-4421.
43. Iyer, L. M., Abhiman, S., Aravind, L., Natural history of eukaryotic DNA methylation systems. Prog. Mol. Biol. Transl. Sci. 2011, 101, 25-104.
44. Saito, M., Ishikawa, F., The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2. J. Biol. Chem. 2002, 277, 35434-35439.
45. Kleefstra, T., Kramer, J. M., Neveling, K., Willemsen, M. H. et al., Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability. Am. J. Hum. Genet. 2012, 91, 73-82.